We still prefer the parent a year later

In 2019, Pfizer decided to focus on its main prescription drug business, which offers investors higher long-term returns than either over-the-counter and generic drugs.
As part of that plan, on November 16, 2020, the pharma giant combined its Upjohn division (generic pharmaceuticals) with Netherlands-based Mylan N.V…. Read More

Brooks opts for a sale over a spinoff

In May 2021, Brooks Automation, a leading supplier of robotic handling and sorting equipment to manufacturers, announced that it would spin off its semiconductor-related operations as a separate firm.
However, Brooks decided instead to sell this business to private equity firm Thomas H. Lee Partners for… Read More

Tap into the future of global health

The Covid-19 pandemic has pushed shares prices for many healthcare stocks—and the ETFs that hold them—to today’s all-time highs. Despite that, the underlying growth trends remain strong as the global population grows older and emerging economies spend more on healthcare.
Here are two ETFs that… Read More